Kenya Country Impact Report


Kenya is one of the largest implementers of grants supported by the Global Fund partnership.
The country has halted and has begun to reverse the HIV epidemic – a disease that seemed unstoppable just 15 years ago. Similar progress has been made in the prevention and treatment of tuberculosis and malaria.
Strong grass-roots, community-based work including the empowerment of women coupled with a strong partnership between Kenya and international partners has helped bolster the response to these diseases.
Devolution of management of health from the national to the local level since 2013 promises to transform the way health care is managed and delivered in the country.
Despite that progress, Kenya still faces challenges in the response to HIV, TB and malaria and in building resilient and sustainable systems for health. With 1.5 million people living with HIV in the country, Kenya has the fourth-largest HIV epidemic in the world. At about 78,000, the number of new HIV infections per year remains high. As for TB, the country is one of the 30 high-burden countries for TB that together account for more than 80 percent of the world’s TB cases. Drug-resistant TB remains a big challenge in the country. As regards malaria, the disease remains a major cause of sickness and death, with more than 70 percent of the population at risk of the disease.